Autism Spectrum Disorder Trial, Recruiting (NCT06817746)

Autism Spectrum Disorder Trial, Recruiting NCT06817746 Sponsor: IRCCS Fondazione Stella Maris Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT06817746 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Babies who score within a certain risk range on a screening tool called the SACS-R (confirm with trial site for details on what score qualifies)
Families where Italian is one of the languages spoken at home
Babies who are under 18 months old (adjusted for any time born prematurely) at the time they are identified for the trial
Families who have access to a device with a webcam and a home internet connection

Who may not be able to join:

Babies who have been diagnosed with a known genetic condition, brain injury, or other significant ongoing neurological or medical condition
Babies who have severe difficulties with vision, hearing, or physical movement

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06817746

Sponsor: IRCCS Fondazione Stella Maris

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

More information: https://clinicaltrials.gov/study/NCT06817746

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Babies who score within a certain risk range on a screening tool called the SACS-R (confirm with trial site for details on what score qualifies)
Families where Italian is one of the languages spoken at home
Babies who are under 18 months old (adjusted for any time born prematurely) at the time they are identified for the trial
Families who have access to a device with a webcam and a home internet connection

Who may not be able to join:

Babies who have been diagnosed with a known genetic condition, brain injury, or other significant ongoing neurological or medical condition
Babies who have severe difficulties with vision, hearing, or physical movement

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

IRCCS Fondazione Stella Maris

Registry

ClinicalTrials.gov

Start date

1 November 2024

Est. completion

31 August 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Infant Development; ASD Symptom Severity; Change of Core ASD Symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov